26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
13 °P sammeln
  • Broschiertes Buch

Prodigiosin, a natural red pigment, is an alkaloid produced by Serratia marcescens and belongs to the prodiginin family whose pigments have three cyclic pyrrolic rings in their chemical structure. This pigment has aroused, in recent years, a growing interest in the medical, pharmaceutical and industrial areas for its biological activities described as antimicrobial, antimalarial and antitumour. In recent years, the search for knowledge about the cytotoxic activity of prodigiosin has been intensified, with cytotoxic effects being described in tumour cell lines such as lung, colon, kidney,…mehr

Produktbeschreibung
Prodigiosin, a natural red pigment, is an alkaloid produced by Serratia marcescens and belongs to the prodiginin family whose pigments have three cyclic pyrrolic rings in their chemical structure. This pigment has aroused, in recent years, a growing interest in the medical, pharmaceutical and industrial areas for its biological activities described as antimicrobial, antimalarial and antitumour. In recent years, the search for knowledge about the cytotoxic activity of prodigiosin has been intensified, with cytotoxic effects being described in tumour cell lines such as lung, colon, kidney, breast, and low toxicity observed in normal cells. However, the genotoxic effects of prodigiosin on cell lines still need to be better elucidated. Due to its antitumour potential and lack of evidence demonstrating genotoxic effects, this study aimed to evaluate the antimicrobial activity of prodigiosin against pathogenic Gram-positive and Gram-negative microorganisms, its cytotoxic effects of thepigment on tumour cell lines, as well as the genotoxic effects.
Autorenporträt
Er promovierte in Biowissenschaften an der Bundesuniversität von Pernambuco. Er arbeitet als Collaborating Researcher in der Abteilung für Antibiotika (UFPEDA). Er war ordentliches Mitglied des Ethik- und Forschungsausschusses des Universitätszentrums UNIFAVIP WYDEN. Er hat Erfahrung in Mikrobiologie, Biotechnologie, Krebsforschung und Molekularbiologie.